Pharmaceutical - Mergers & Acquisitions, Boehringer Ingelheim

Filter

Popular Filters

Boehringer Ingelheim Venture Fund invests in Eyevensys

15-04-2013

Paris, France-based Eyevensys, a developer of a new process for non-viral gene therapy using electrotransfer…

Boehringer IngelheimEyevensysFinancialMergers & AcquisitionsOphthalmicsPharmaceutical

In India, Lilly and Boehringer link for diabetes drug marketing; GSK eyeing acquisitions

04-10-2011

The Indian subsidiaries of US drug major Eli Lilly (NYSE: LLY) and independent German pharma company…

Asia-PacificBoehringer IngelheimDiabetesEli LillyGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceutical

Back to top